This is a preprint.
A gut pathobiont regulates circulating glycine and host metabolism in a twin study comparing vegan and omnivorous diets
- PMID: 39830242
- PMCID: PMC11741504
- DOI: 10.1101/2025.01.08.25320192
A gut pathobiont regulates circulating glycine and host metabolism in a twin study comparing vegan and omnivorous diets
Abstract
Metabolic diseases including type 2 diabetes and obesity pose a significant global health burden. Plant-based diets, including vegan diets, are linked to favorable metabolic outcomes, yet the underlying mechanisms remain unclear. In a randomized trial involving 21 pairs of identical twins, we investigated the effects of vegan and omnivorous diets on the host metabolome, immune system, and gut microbiome. Vegan diets induced significant shifts in serum and stool metabolomes, cytokine profiles, and gut microbial composition. Despite lower dietary glycine intake, vegan diet subjects exhibited elevated serum glycine levels linked to reduced abundance of the gut pathobiont Bilophila wadsworthia. Functional studies demonstrated that B. wadsworthia metabolizes glycine via the glycine reductase pathway and modulates host glycine availability. Removing B. wadsworthia from a complex microbiota in mice elevated glycine levels and improved metabolic markers. These findings reveal a previously underappreciated mechanism by which diet regulates host metabolic status via the gut microbiota.
Conflict of interest statement
Declaration of interests Stanford University and the Chan Zuckerberg Biohub have patents pending for microbiome technologies on which the authors are co-inventors. M.A.F. is a co-founder and director of Federation Bio and Kelonia, a co-founder of Revolution Medicines, an Innovation Partner at the Column Group, and a member of the scientific advisory board of NGM Bio. All other authors have no competing interests.
Figures
References
-
- Chew N.W.S., Ng C.H., Tan D.J.H., Kong G., Lin C., Chin Y.H., Lim W.H., Huang D.Q., Quek J., Fu C.E., et al. (2023). The global burden of metabolic disease: Data from 2000 to 2019. Cell Metab. 35, 414–428.e3. - PubMed
-
- Timmis A., Vardas P., Townsend N., Torbica A., Katus H., De Smedt D., Gale C.P., Maggioni A.P., Petersen S.E., Huculeci R., et al. (2022). European Society of Cardiology: cardiovascular disease statistics 2021. Eur. Heart J. 43, 716–799. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources